Massive european data merge aims to unlock blood clot mysteries

This study is not testing a new drug or treatment. Instead, researchers are combining health information from 20,000 people across 14 European groups who have had blood clots (venous thromboembolism). By merging this data, they hope to better understand who is at risk for future clots, bleeding, or death. The goal is to improve how doctors predict and manage these conditions.